Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Billeskov

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Immunology|January 31, 2018
High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against TuberculosisRolf Billeskov, Thomas Lindenstrøm, Joshua Woodworth, et al.
Plos One|August 16, 2016
Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of TuberculosisRolf Billeskov, Esterlina V Tan, Marjorie Cang, et al.
Plos Pathogens|May 13, 2017
Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaquesYongjun Sui, Blake Frey, Yichuan Wang, et al.
Nature Medicine|January 25, 2011
A multistage tuberculosis vaccine that confers efficient protection before and after exposureClaus Aagaard, Truc Hoang, Jes Dietrich, et al.
Plos One|June 17, 2009
Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen doseClaus Aagaard, Truc Thi Kim Thanh Hoang, Angelo Izzo, et al.
BJUI Compass|August 19, 2024
Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohortGoran Bencina, Rolf Billeskov, Rasmine Bak, et al.
Journal of Leukocyte Biology|October 16, 2015
Lack of the programmed death-1 receptor renders host susceptible to enteric microbial infection through impairing the production of the mucosal natural killer cell effector moleculesShahram Solaymani-Mohammadi, Omar Lakhdari, Ivelina Minev, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 28, 2018
Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell ImmunityBlake F Frey, Jiansheng Jiang, Yongjun Sui, et al.
European Journal of Immunology|February 27, 2010
Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosisRolf Billeskov, Michael V Grandal, Christian Poulsen, et al.
Scientific Reports|January 22, 2016
Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogensNiels Peter H Knudsen, Anja Olsen, Cecilia Buonsanti, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Immunology|January 31, 2018
High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against TuberculosisRolf Billeskov, Thomas Lindenstrøm, Joshua Woodworth, et al.
Plos One|August 16, 2016
Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of TuberculosisRolf Billeskov, Esterlina V Tan, Marjorie Cang, et al.
Plos Pathogens|May 13, 2017
Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaquesYongjun Sui, Blake Frey, Yichuan Wang, et al.
Nature Medicine|January 25, 2011
A multistage tuberculosis vaccine that confers efficient protection before and after exposureClaus Aagaard, Truc Hoang, Jes Dietrich, et al.
Plos One|June 17, 2009
Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen doseClaus Aagaard, Truc Thi Kim Thanh Hoang, Angelo Izzo, et al.
BJUI Compass|August 19, 2024
Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohortGoran Bencina, Rolf Billeskov, Rasmine Bak, et al.
Journal of Leukocyte Biology|October 16, 2015
Lack of the programmed death-1 receptor renders host susceptible to enteric microbial infection through impairing the production of the mucosal natural killer cell effector moleculesShahram Solaymani-Mohammadi, Omar Lakhdari, Ivelina Minev, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 28, 2018
Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell ImmunityBlake F Frey, Jiansheng Jiang, Yongjun Sui, et al.
European Journal of Immunology|February 27, 2010
Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosisRolf Billeskov, Michael V Grandal, Christian Poulsen, et al.
Scientific Reports|January 22, 2016
Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogensNiels Peter H Knudsen, Anja Olsen, Cecilia Buonsanti, et al.
Pageof 2